Summary:
Study evaluating the safety and therapeutic value of an investigational drug on lowering the chances of heart disease in patients with Type II Diabetes.
Qualified Participants Must:
• be 45 to 79 years old
•
have Type II Diabetes (Adult Onset) controlled by diet, oral medication or insulin
•
not be taking Avandia® or Actos®
Qualified Participants May Receive:
$360.00 and free scans to check for blocked arteries.